Positive News SentimentPositive NewsNASDAQ:CERS Cerus (CERS) Stock Price, News & Analysis $1.40 +0.02 (+1.45%) Closing price 04:00 PM EasternExtended Trading$1.30 -0.11 (-7.50%) As of 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Cerus Stock (NASDAQ:CERS) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Cerus alerts:Sign Up Key Stats Today's Range$1.35▼$1.4250-Day Range$1.38▼$2.1552-Week Range$1.29▼$2.54Volume1.32 million shsAverage Volume1.24 million shsMarket Capitalization$260.11 millionP/E RatioN/ADividend YieldN/APrice Target$4.00Consensus RatingBuy Company OverviewCerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company offers INTERCEPT Blood Systems for platelets and plasma, which is designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells donated for transfusion; and INTERCEPT Blood System for Cryoprecipitation that uses its plasma system to produce pathogen reduced cryoprecipitated fibrinogen complex for the treatment and control of bleeding, including massive hemorrhage associated with fibrinogen deficiency, as well as pathogen reduced plasma, cryoprecipitate reduced. It sells platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America, and internationally. Cerus Corporation was incorporated in 1991 and is headquartered in Concord, California.Read More… Remove Ads Cerus Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks50th Percentile Overall ScoreCERS MarketRank™: Cerus scored higher than 50% of companies evaluated by MarketBeat, and ranked 577th out of 930 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingBuy Consensus RatingCerus has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageCerus has only been the subject of 1 research reports in the past 90 days.Read more about Cerus' stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Cerus are expected to grow in the coming year, from ($0.08) to ($0.06) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Cerus is -12.73, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Cerus is -12.73, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioCerus has a P/B Ratio of 4.83. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Cerus' valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted5.71% of the float of Cerus has been sold short.Short Interest Ratio / Days to CoverCerus has a short interest ratio ("days to cover") of 6.7.Change versus previous monthShort interest in Cerus has recently increased by 1.49%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldCerus does not currently pay a dividend.Dividend GrowthCerus does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted5.71% of the float of Cerus has been sold short.Short Interest Ratio / Days to CoverCerus has a short interest ratio ("days to cover") of 6.7.Change versus previous monthShort interest in Cerus has recently increased by 1.49%, indicating that investor sentiment is decreasing. News and Social Media3.3 / 5News SentimentN/A News SentimentCerus has a news sentiment score of 1.87. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.58 average news sentiment score of Medical companies.Search InterestOnly 3 people have searched for CERS on MarketBeat in the last 30 days. This is a decrease of -25% compared to the previous 30 days.MarketBeat Follows2 people have added Cerus to their MarketBeat watchlist in the last 30 days. Company Ownership2.5 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Cerus insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $665,210.00 in company stock.Percentage Held by InsidersOnly 3.40% of the stock of Cerus is held by insiders.Percentage Held by Institutions78.37% of the stock of Cerus is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Cerus' insider trading history. Receive CERS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cerus and its competitors with MarketBeat's FREE daily newsletter. Email Address CERS Stock News HeadlinesCerus Co. (NASDAQ:CERS) Insider Richard J. Benjamin Sells 18,949 SharesMarch 18, 2025 | insidertrades.comCerus Co. (NASDAQ:CERS) Insider Richard J. Benjamin Sells 26,139 SharesMarch 11, 2025 | insidertrades.comTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's coming next. But here's the truth… This is just the beginning. Trump has made it clear his tariffs are coming, and that the market will get worse before it gets better. Luckily, our FREE Presidential Transition Guide details exactly what will happen in the next 100 days, and how to protect your hard-earned savings during these times. Don't wait for the next crash to wipe you out. Act now.April 2, 2025 | American Alternative (Ad)Insider Selling: Cerus Co. (NASDAQ:CERS) COO Sells 10,780 Shares of StockMarch 6, 2025 | insidertrades.comAre Investors Undervaluing Cerus Corporation (NASDAQ:CERS) By 49%?March 21, 2025 | finance.yahoo.comCerus receives CE mark for next-generation INTERCEPT illumination deviceMarch 6, 2025 | markets.businessinsider.comCerus Corporation Announces Receipt of CE Mark for Next-Generation INTERCEPT Illumination Device (INT200)March 5, 2025 | businesswire.comBTIG Reaffirms Their Hold Rating on Cerus (CERS)February 25, 2025 | markets.businessinsider.comSee More Headlines CERS Stock Analysis - Frequently Asked Questions How have CERS shares performed this year? Cerus' stock was trading at $1.54 on January 1st, 2025. Since then, CERS stock has decreased by 9.1% and is now trading at $1.40. View the best growth stocks for 2025 here. How were Cerus' earnings last quarter? Cerus Co. (NASDAQ:CERS) announced its quarterly earnings data on Thursday, February, 20th. The biotechnology company reported ($0.01) EPS for the quarter, hitting analysts' consensus estimates of ($0.01). The biotechnology company earned $50.81 million during the quarter, compared to analysts' expectations of $50.81 million. Cerus had a negative trailing twelve-month return on equity of 40.55% and a negative net margin of 11.60%. How do I buy shares of Cerus? Shares of CERS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Cerus own? Based on aggregate information from My MarketBeat watchlists, some other companies that Cerus investors own include American Water Works (AWK), Waste Connections (WCN), DiamondRock Hospitality (DRH), The RMR Group (RMR), Voyager Therapeutics (VYGR), AUO (AUOTY) and iShares Micro-Cap ETF (IWC). Company Calendar Last Earnings2/20/2025Today4/02/2025Next Earnings (Estimated)5/01/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryHealth Care Supplies Current SymbolNASDAQ:CERS CIK1020214 Webwww.cerus.com Phone(925) 288-6000Fax925-288-6001Employees290Year Founded1991Price Target and Rating Average Stock Price Target$4.00 High Stock Price Target$5.00 Low Stock Price Target$3.00 Potential Upside/Downside+189.9%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)($0.11) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-37,490,000.00 Net Margins-11.60% Pretax Margin-11.13% Return on Equity-40.55% Return on Assets-11.12% Debt Debt-to-Equity Ratio1.19 Current Ratio2.59 Quick Ratio1.92 Sales & Book Value Annual Sales$180.27 million Price / Sales1.42 Cash FlowN/A Price / Cash FlowN/A Book Value$0.29 per share Price / Book4.76Miscellaneous Outstanding Shares185,790,000Free Float179,401,000Market Cap$256.39 million OptionableOptionable Beta1.56 Social Links Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report This page (NASDAQ:CERS) was last updated on 4/2/2025 by MarketBeat.com Staff From Our PartnersTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cerus Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cerus With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.